The 2008 federal parity law and the 2010 Affordable Care Act (ACA) sought to expand access to behavioral health services. There was concern plans might discourage enrollment by individuals with behavioral health conditions who tend to be higher cost. This study compared behavioral health benefits available in the group insurance market (non-marketplace) to those sold through the ACA marketplaces to check for evidence of less generous behavioral health coverage in marketplace plans.
Data were from a 2014 nationally representative survey of commercial health plans regarding behavioral health services (80% response rate). The sample included the most common silver marketplace product, and as a comparison, the most common non-marketplace product of the same type (e.g., HMO, PPO) from each health plan (N = 106 marketplace and non-marketplace pairs or 212 products).
Marketplace and non-marketplace products were similar in terms of coverage, prior authorization, and continuing review requirements. Marketplace products were more likely to employ narrow and tiered behavioral health provider networks. Narrow and tiered networks were more common in state than federal marketplaces.
Provider network design is a tool that health plans may use to control cost and possibly discourage enrollment by high-cost users, including those with behavioral health conditions. The Affordable Care Act was successful in ensuring robust behavioral health coverage in marketplace plans. As the marketplaces evolve or are replaced, these data provide an important baseline to which we can compare future systems.
The 2008 Mental Health Parity & Addiction Equity Act (MHPAEA) and the 2010 Affordable Care Act (ACA) expanded access to behavioral health services. As policymakers debate changes to the ACA, it is helpful to understand how product design evolved in this context. Insurance options moving forward are likely to continue to rely on competition among insurers, making recent experience with marketplaces relvant. MHPAEA requires insurers to cover behavioral health and general medical services similarly in commercial large-group insurance products. The ACA expanded MHPAEA to apply to coverage available through ACA-established individual health insurance marketplaces and state Medicaid programs. Since the ACA included behavioral health services in the essential health benefits package, insurers offering products in the marketplace must cover behavioral health services at the same level as the state’s benchmark plan. Together, these policies expanded access to behavioral health treatment to an estimated 62.5 million individuals (1) and increased Medicaid and private insurance coverage in 2014 and 2015 (2, 3).
Despite regulations, marketplace plans have flexibility in designing benefit structures and implementing managed care practices. Plan design options include deductible and copayment amounts, covered services, and when to apply prior authorization and continuing review. Plans could offer narrow networks that exclude many providers or design tiered networks that charge enrollees more for using less-preferred providers.
These choices are particularly acute for individuals with behavioral health conditions and individuals and small businesses purchasing their own insurance in the marketplace. For insurers, individuals with behavioral health conditions are among the least desirable to insure (4), partially because spending on their care predictably exceeds premiums. In health economics, adverse selection occurs when, “Individuals who expect high health care costs, differentially prefer more generous and expensive insurance plans; those who expect low costs choose more moderate plans.” (5). There is concern that insurers may offer less generous behavioral health coverage to discourage enrollment, particularly in individual and small group products where health care users make purchasing decisions rather than human resources departments (6). While the ACA risk adjustment provisions were designed to reduce selection incentives, behavioral health risk adjustment methods are less developed and often not effective (4, 7, 8). A simulation of the ACA marketplace risk-adjustment method showed it did not cover the higher costs of 80% of individuals with behavioral health conditions (9).
Thus, while MHPAEA requires coverage for behavioral health conditions at parity with general medical conditions, health plans retain incentives to select members and a significant amount of discretion over covered services (9, 10). Coverage, network design, and cost-sharing are features that health plan and marketplace websites make available to consumers prior to selecting a plan, unlike other features unobservable to consumers at that point (e.g. prior authorization) (11).
While the future of the ACA is unknown, the federal government may shift responsibility for marketplace oversight to states, (12) and incentives to avoid individuals with behavioral health conditions are likely to continue and may strengthen. The objective of this paper is to assess whether marketplace plans structure benefit design to avoid costly cases. To assess this, we compare products in the health insurance marketplaces to those available in the employer-based group insurance market (non-marketplace), in terms of behavioral health coverage, management, and network size. The hypothesis is that for a given product, behavioral health benefits will be less generous and management will be more stringent in marketplace products than in non-marketplace products. Results provide a baseline for comparison of proposed reforms and continued performance of marketplace products.
Data were from a nationally representative telephone survey of senior health plan executives, collected August 2014–April 2015. Questions about the behavioral health services offered in 2014 were asked at the product-level (e.g., health maintenance organization [HMO], preferred provider organization [PPO]) within each market area–specific plan). Questions were asked about the plan’s three commercial products with the highest enrollment (non-marketplace)–primarily the employer-sponsored group market–and top silver product (marketplace) designed for the individual market.
A panel design with replacement was used and has been described previously (13). The national sample from 2010 was augmented for 2014 with plans not previously operating in the market areas. The primary sampling units were the 60 market areas selected by the Community Tracking Study to be nationally representative (14). The second stage sampled plans within markets. If plans served multiple market areas, they were defined separately, and data were collected by market area. For some national or regional plans, respondents were interviewed regarding multiple sites. In 2014, 344 eligible plans were identified, 274 responded (80%), reporting on 705 commercial products and 121 silver products. The — IRB approved the study.
Marketplace products are classified by actuarial value in four levels. This study focused on silver products (third level) because they were the most commonly purchased type in the marketplace, selected by 70% of participants (15) and the only level eligible for federally-subsidized cost-sharing reductions. Silver products therefore provide the most financial assistance for participants.
The analytic sample was created by pairing each health plan’s top silver product with their non-marketplace product of the same type. For instance, if the silver product that the plan reported on was an HMO, the plan’s top non-marketplace HMO product was selected for the analytic sample. Fifteen marketplace products from plans without a non-marketplace product of the same type were excluded. The resulting sample consisted of 106 pairs of silver marketplace and non-marketplace products from the same health plans, for a total of 212 products.
Product pairs were compared across health plan characteristics and management domains. Plan characteristics included product type (HMO, PPO, or POS); contracting arrangement: external (contracted with an MBHO for delivery and management of behavioral health) or internal (all behavioral health services are provided by plan employees, or by a specialty behavioral health organization that is part of the same parent organization, or by a network of providers administered by the plan), whether the plan is national (offers products in multiple states/market areas throughout the US), profit status (non- or for-profit), census region (Northeast, Midwest, South, or West), and marketplace type (administered by the state, by the federal government, or in a joint state and federal “partnership” arrangement).
Health plan management domains included covered services, prior authorization, continuing review, network design, and cost-sharing. Services that plans could cover included a continuum of mental health and substance use services. Prior authorization and continuing review are policies under which providers and beneficiaries must actively seek health plan approval before initiating certain services or continuing care after a predetermined amount has been received.
Network design included measures of use of narrow and tiered networks for primary care providers and behavioral health providers. Narrow networks limit the pool of providers available to beneficiaries on the basis of characteristics such as cost, availability, and quality. Narrow networks were defined as networks comprised of selected, high-value providers, restricting enrollees to use only these providers and hospitals.
Tiered networks may comprise a larger group of providers to choose from than narrow networks. They function similarly to drug formularies, but feature multiple cost-sharing tiers for providers, with providers preferred by the health plan having lower copays or coinsurance rates than non-preferred providers. Tiered networks were defined as, “Hospitals or physicians that meet criteria imposed by the health plan are identified and favorable financial terms are provided to patients who seek care at those providers”.
The survey asked about narrow and tiered networks for primary care providers, specialty medical providers and specialty behavioral health providers. Finally, the survey asked how the network of behavioral health providers available for the silver marketplace product compares to the commercial network for the same product, with answer choices of smaller, larger, about the same.
Cost-sharing measures included the type of cost-sharing (i.e., copays or coinsurance) for in-network behavioral health and medical care, as well as level of patient cost-sharing (average dollar amount for copays and percentage for coinsurance) for in-network behavioral health care.
Statistical analyses used SAS version 9.3. Results are reported at the product level and are based on non-missing values. Observed differences in outcomes between the matched sample of marketplace and non-marketplace plans were tested for statistical significance using t-tests for dependent samples.
Among product pairs, HMO products were the most common ( Table 1 ). The majority of products were offered by nonprofit companies (56%, N=59) and not national plans (70%, N=74). Almost half of marketplace products (N=48) in this sample were offered on state-based marketplaces, 37%, N=39 were on federally-facilitated marketplaces and 18%, N=19 were through state partnership marketplaces.
Plan Characteristics | Analytic sample: Pairs of marketplace and non-marketplace products | Nationally representative sample: Non-marketplace Products | ||||
---|---|---|---|---|---|---|
N = 106 | N = 6,974 | |||||
# | % | SE | # | % | SE | |
Product type (product level) | ||||||
HMO * | 55 | 52 | 4 | 2355 | 34 | 1 |
PPO * | 47 | 44 | 4 | 2478 | 36 | 1 |
POS * | 4 | 4 | 2 | 900 | 13 | 1 |
CDP * | 0 | 0 | 0 | 1241 | 18 | 1 |
Contracting arrangement | ||||||
External * | 25 | 24 | 3 | 10 | 2 | |
Internal * | 81 | 76 | 3 | 90 | 2 | |
Multi-site health plan / National plan | ||||||
Yes * | 30 | 5 | 76 | 2 | ||
Profit status | ||||||
For profit * | 47 | 44 | 4 | 5679 | 81 | 2 |
Non profit | 59 | 56 | 4 | 1295 | 19 | 2 |
Region | ||||||
Northeast | 16 | 15 | 3 | 1798 | 26 | 8 |
Midwest * | 21 | 20 | 3 | 733 | 11 | 3 |
South | 42 | 40 | 4 | 2910 | 42 | 7 |
West | 27 | 25 | 4 | 1532 | 22 | 7 |
Type of marketplace | ||||||
Federally-faciliated Marketplaces | 39 | 37 | 5 | n/a | n/a | n/a |
State Partnership Marketplaces | 19 | 18 | 4 | n/a | n/a | n/a |
State-based Marketplace | 48 | 45 | 5 | n/a | n/a | n/a |
The analytic sample of plans offering both marketplace and non-marketplace products differs in some ways from the nationally representative sample of commercial (non-marketplace) plans ( Table 1 ). Compared to the nationally representative sample, a higher proportion of plans offering marketplace products managed behavioral health services externally (24%, N=25, of the analytic sample; 10%, N=704 of the nationally representative sample). Plans with a marketplace product were also more likely to be non-profit and to be from the Midwest than the nationally representative sample.
Each service was covered by a large majority of marketplace and non-marketplace products ( Table 2 ). For mental health care, all products covered inpatient, partial hospital or day treatment, and outpatient therapy. In both samples, 94%, N=96 covered mental health crisis services and the vast majority covered mental health residential services. For substance use treatment, all products covered inpatient or residential detoxification, inpatient, and outpatient therapy. In both samples, most products also covered substance use residential, intensive outpatient, outpatient opioid treatment programs, and 24-hour crisis services. There were not any statistically significant differences in coverage between marketplace and non-marketplace products.
Covered Services, 2014
Marketplace products a | Non-marketplace products b | |||||
---|---|---|---|---|---|---|
N = 106 | N = 106 | |||||
Service | # | % | SE | # | % | SE |
Mental Health Services | ||||||
Inpatient hospital | 106 | 100 | 0 | 106 | 100 | 0 |
Non-hospital residential | 89 | 86 | 3 | 84 | 85 | 3 |
Partial hospital, or day treatment | 106 | 100 | 0 | 106 | 100 | 0 |
Outpatient counseling or therapy | 106 | 100 | 0 | 106 | 100 | 0 |
Crisis services available 24 hours a day | 96 | 94 | 2 | 96 | 94 | 2 |
Substance Use Services | ||||||
Inpatient or residential detoxification | 106 | 100 | 0 | 106 | 100 | 0 |
Inpatient hospital | 106 | 100 | 0 | 106 | 100 | 0 |
Residential rehabilitation | 98 | 92 | 2 | 98 | 92 | 2 |
Intensive outpatient, partial hospital, or day treatment | 105 | 99 | 1 | 105 | 99 | 1 |
Outpatient counseling/therapy | 106 | 100 | 0 | 106 | 100 | 0 |
Outpatient opioid treatment programs | 99 | 93 | 2 | 98 | 92 | 2 |
Crisis services available 24 hours/day | 97 | 95 | 2 | 97 | 95 | 2 |
Excluded Diagnoses | ||||||
Alcohol disorders | 0 | 0 | 0 | 0 | 0 | 0 |
Drug use disorders | 0 | 0 | 0 | 0 | 0 | 0 |
Eating disorders | 0 | 0 | 0 | 0 | 0 | 0 |
ADHD | 1 | 1 | 1 | 1 | 1 | 1 |
Autsim spectrum disorders | 7 | 7 | 2 | 7 | 7 | 2 |
All calculations based on full sample except for non-hospital residential (6% missing) and crisis services (4% missing).
a Marketplace product: Most frequently purchased silver product which is designed for the individual market.
b Non-marketplace product: one of plan’s three commercial products with the highest enrollment which were primarily for the employer-sponsored group market.
Prior authorization requirements were not significantly different between the marketplace and non-marketplace products ( Table 3 ). In both samples, outpatient counseling for substance use disorders was least likely to require prior authorization (13%, N=14). In marketplace and non-marketplace products prior authorization was most frequently applied for residential rehabilitation related to substance use disorders, with 97%, N=95 of marketplace and non-marketplace products reporting the use of prior authorization.
Prior Authorization, Continuing Review & Network Design, 2014
Marketplace products a | Non-marketplace products b | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
N = 106 | N = 106 | |||||||||||
Service | # | % | SE | # | % | SE | ||||||
Prior Authorization | ||||||||||||
Inpatient hospital treatment for mental disorders | 86 | 81 | 3 | 84 | 79 | 3 | ||||||
Inpatient or residential detoxification | 86 | 81 | 3 | 86 | 81 | 3 | ||||||
Residential rehabilitation for substance use disorders | 95 | 97 | 1 | 95 | 97 | 1 | ||||||
Intensive outpatient or day treatment for substance use disorders | 77 | 73 | 4 | 77 | 73 | 4 | ||||||
Outpatient opioid treatment programs | 41 | 42 | 4 | 40 | 41 | 4 | ||||||
Outpatient counseling for substance use disorders | 14 | 13 | 3 | 14 | 13 | 3 | ||||||
Continuing Review | ||||||||||||
Inpatient hospital treatment for mental disorders | 102 | 96 | 1 | 101 | 95 | 1 | ||||||
Residential rehabilitation for substance use disorders | 92 | 97 | 1 | 92 | 97 | 1 | ||||||
Intensive outpatient or day treatment for substance use disorders | 87 | 83 | 3 | 87 | 83 | 3 | ||||||
Outpatient opioid treatment programs | 45 | 51 | 4 | 45 | 51 | 4 | ||||||
Outpatient counseling for substance use disorders | 34 | 33 | 3 | 34 | 33 | 3 | ||||||
Network Design | ||||||||||||
Narrow Network | ||||||||||||
General medical providers * | 71 | 67 | 4 | 49 | 46 | 3 | ||||||
Behavioral health providers * | 17 | 16 | 3 | 12 | 11 | 2 | ||||||
Tiered Network | ||||||||||||
General medical providers | 28 | 28 | 3 | 26 | 26 | 3 | ||||||
Behavioral health providers * | 14 | 14 | 2 | 8 | 8 | 2 |
All calculations based on full sample, except for tiered network variables where 6 products reporting ‘don’t know’ were excluded from calculation.
a Marketplace product: Most frequently purchased silver product which is designed for the individual market.
b Non-marketplace product: one of plan’s three commercial products with the highest enrollment which were primarily for the employer-sponsored group market.
Continuing review policies did not differ significantly between marketplace and non-marketplace products ( Table 3 ). Continuing review was required least frequently for outpatient counseling for substance use disorders (33%, N=34) and outpatient opioid treatment programs (51% N=45). Nearly all products required continuing review for inpatient hospital treatment for mental health (96%, N=102 for marketplace, 95%, N=101 for non-marketplace) and residential rehabilitation for substance use disorders (97%, N=92 for both marketplace and non-marketplace).
Marketplace products were significantly more likely to utilize narrow network designs than non-marketplace products ( Table 3 ) for both general medical providers (67%, N=71 for marketplace, 46%, N=49 non-marketplace) and behavioral health providers (16%, N=17 for marketplace, 11%, N=12 non-marketplace). Tiered networks were less common than narrow networks in both provider categories, but were used more frequently by marketplace than non-marketplace products for behavioral health providers (14%, N=14 for marketplace, 8%, N=8 for non-marketplace).
Differences were found in marketplace products offered through state versus federal marketplaces. ( Table 4 ). Products offered in state marketplaces were more likely to report using narrow networks for behavioral health providers (24% N=16 state, 3% N=1 federal). Although tiered networks for behavioral health providers were not used frequently, they were more common in products offered in state marketplaces than in federal marketplaces (20% N=12 state, 5% N=2 federal).
Comparison network designs in federal and state marketplaces, 2014
Network design | Federal Marketplace N = 39 | State Marketplace N = 67 | ||||
---|---|---|---|---|---|---|
# | % | SE | # | % | SE | |
Narrow Network | ||||||
General medical providers | 27 | 69 | 6 | 44 | 66 | 4 |
Behavioral health providers * | 1 | 3 | 2 | 16 | 24 | 4 |
Tiered Network | ||||||
General medical providers | 10 | 26 | 5 | 18 | 30 | 4 |
Behavioral health providers * | 2 | 5 | 3 | 12 | 20 | 3 |
All calculations based on full sample, except for tiered network variable where 6 products reporting ‘don’t know’ were excluded from calculation.
Small, significant differences were found in the type of cost-sharing for in-network medical and behavioral health outpatient care between marketplace and non-marketplace products ( Table 5 ). Marketplace products were less likely to require copays for both types of care than non-marketplace products (75%, N=54 marketplace, 80%, N=62 non-marketplace) The mean copayments for in-network specialty outpatient behavioral health care were almost identical. The mean coinsurance was 20% for marketplace products and 25% for non-marketplace products.
Member cost sharing, 2014
Marketplace products a | Non-marketplace products b | |||||
---|---|---|---|---|---|---|
N = 72 | N = 78 | |||||
# | % | SD | # | % | SD | |
Type of cost-sharing for in-network outpatient care | ||||||
Copay for both BH and general medical * | 54 | 75 | 44 | 62 | 80 | 41 |
Coinsurance for both | 12 | 17 | 38 | 10 | 13 | 34 |
Copay for BH, coinsurance for GM * | 11 | 15 | 36 | 11 | 14 | 35 |
Coinsurance for BH, copay for GM | 5 | 7 | 26 | 5 | 6 | 25 |
Level of patient cost-sharing for in-network specialty behavioral health outpatient treatment | # | mean | SD | # | mean | SD |
Copayment $ | 62 | 29 | 18 | 71 | 28 | 17 |
Coinsurance * % | 10 | 20 | 0 | 8 | 25 | 5 |
All calculations are for non-missing data. Type and level of cost sharing are missing for 32% of silver marketplace products and 26% of non-marketplace products. N represents non-missing data.
Despite concerns that plans might reduce benefits to avoid costly cases, the marketplace products in this sample were not more restrictive in terms of their behavioral health coverage, prior authorization requirements or patient cost-sharing than non-marketplace products from the same health plans. This indicates that access to behavioral health services was not limited on the marketplaces by these measures. One possible explanation is that the MHPAEA regulations prevented plans from using approaches that differed greatly between behavioral health and general medical care. Another explanation is that this study was conducted during the first year of the marketplaces (2014), when financial protections for health plans, including risk-adjustment, risk-corridors and reinsurance were in place. If in future these protections are weakened, the generosity of behavioral health coverage may diminish.
Marketplace products were more likely to use narrow and tiered networks for general health services, which has important implications for individuals receiving behavioral health services in primary care settings (17). Behavioral health conditions are increasingly treated in primary care (16). Non-psychiatrist physicians write the majority of new psychotropic prescriptions (17). Individuals with behavioral health conditions frequently have co-occurring medical conditions. For these reasons, both primary care and behavioral health networks affect access to behavioral health care. Thus, while most products did not report restricting behavioral health provider networks, restrictions on primary care provider networks may disproportionately discourage individuals with behavioral health conditions from enrollment.
Differences in marketplace products between federal and state marketplaces are important. If ACA reform shifts responsibility to the states, the new system may look more like the state marketplaces. In this study, products on state marketplaces were more likely to use narrow and tiered networks for behavioral health providers, making access to behavioral health providers more challenging.
Other researchers found that group insurance products/non-marketplace products were more likely to be actuarially equivalent to gold and platinum marketplace products (18), suggesting that silver marketplace products are likely to be less generous than non-marketplace products. The current study did not examine premiums or deductibles, important factors in determining actuarial value; however, in terms of coverage, cost-sharing and utilization management, the silver products were similar to non-marketplace products.
It is possible that plans choosing to enter marketplaces are systematically different from plans that do not offer marketplace products. Comparing these findings to our national sample of health plans shows lower rates of coverage for behavioral health services and some indication that plans operating in marketplaces manage access more strictly. Although coverage rates are generally high, plans that offer both commercial and marketplace products are less likely to cover residential care, crisis services for SUD and MH and opioid treatment services and are more likely to require prior authorization for outpatient services in their commerical products, compared to plans that only offer commercial products (19). Future research should examine further differences among plans by marketplace participation.
Although selected from a nationally representative sample of private health plans, the analytic sample is not itself nationally representative. Excluded are health plans that do not operate in commercial health insurance markets except through the marketplaces, including for example, those that specialize in the Medicaid population and have expanded to marketplace products. The large national sample of health plans is strengthened by the comparison between marketplace and non-marketplace products from the same health plans. Most measures had complete data, and the overall survey had a response rate of 80%. Increased non-response on cost-sharing information may reflect the complexity of cost-sharing arrangements employed by insurers. This study examined several policies indicative of health plan coverage and generosity but did not assess premiums or deductibles. Health plan products may differ in these and other unmeasured ways, including provider payment rates, stringency of medical necessity criteria, use of quality improvement programs, and other administrative procedures (20). The findings are based on a survey of health plan executives and may not reflect the actual experience of individuals when they try to access behavioral health services (21). Executives were asked about network policies, but network size was not quantified. Therefore, we may not identify networks that are narrow due to either lack of provider availability or lack of provider participation possibly driven by low payment rates. Clear definitions of narrow networks have not been established; results may vary depending on the definition.
In 2014, insurers appeared to be relying more on network design than on coverage, utilization management or cost-sharing to address the special challenges of cost-management in marketplaces. This may reflect weaker government regulation of network management than other plan features. As the federal government shifts more responsibility for oversight to states (12), networks remain important to monitor.
Health plan products are more likely to develop narrow networks for primary care providers and in state marketplaces. Prevalence of narrow network products on state marketplaces varies, depending on methods and definintion, but is substantial (22, 23). A recent study shows that narrow network marketplace products have lower premiums (24). Together with findings that products do not differ on other dimensions, these findings support the idea that networks are the key feature on which plans are now competing and may also be used to encourage selection of healthier enrollees (25).
Overall, the ACA was successful in ensuring that robust behavioral health coverage was available in marketplace plans; today’s insurance environment is uncertain (26). The number of insurers participating in the marketplaces has declined from more than 6 per state in 2015 to about 4 per state in 2017, with many counties having one or zero insurers (27, 28). Efforts to improve risk adjustment and extend reinsurance, which can help insurance companies when costs exceed premiums, may provide the stability insurers need to continuing operating in marketplaces. Without more stability, improvements in access achieved by the ACA could be eliminated even if the law is not repealed. Proposed repeal plans have envisioned eliminating mandates on individuals to purchase insurance and on plans to cover benefits defined as essential, which include behavioral health services. Without those requirements, individuals with behavioral health conditions will again be at risk. Findings from this study provide an important indicator of features to track and baseline information to which we can compare future systems.
This study was supported by NIDA R01 DA029316, NIAAA R01AA01086 and by the NIDA — (P30 DA035772).
The authors acknowledge the contributions of Pat Nemeth, Frank Potter, Ph.D., and the staff at Mathematica Policy Research, Inc., for survey design, statistical consultation, and data collection; Grant Ritter, Ph.D., for statistical consultation; and Galina Zolotusky, M.S., for statistical programming.
Disclosures:
The authors report no conflicts of interest.
Previous presentation: A preliminary version of these results was presented at the 2016 Addiction Health Services Research Conference in Seattle, WA on October 15, 2016.
Maureen T. Stewart, The Heller School, Brandeis University - Institute for Behavioral Health, Waltham, Massachusetts, ude.siednarb@trawetsm.
Constance Horgan, Brandeis University - Schneider Center for Behavioral Health, Waltham, Massachusetts.
Dominic Hodgkin, Brandeis University - Heller School, Waltham, Massachusetts.
Timothy B. Creedon, The Heller School, Brandeis University - Institute for Behavioral Health, Waltham, Massachusetts.
Amity Quinn, Cumming School of Medicine, University of Calgary - Department of Community Health Sciences, Calgary, Canada.
Lindsay Garito, The Heller School, Brandeis University, Waltham, Massachusetts.
Sharon Reif, Brandeis University - Heller School, Waltham, Massachusetts.
Deborah W. Garnick, Brandeis University - Heller School for Social Policy and Management.
1. Beronio K, Po R, Skopec L, et al. ASPE Research Brief. Washington DC: 2013. Affordable Care Act will expand mental health and substance use disorder benefits and parity protections for 62 million Americans. [Google Scholar]
2. Saloner B. An Update on “Insurance Coverage and Treatment Use Under the Affordable Care Act Among Adults With Mental and Substance Use Disorders” Psychiatric Services. 2017; 68 :310–311. [PubMed] [Google Scholar]
3. Saloner B, Bandara S, Bachhuber M, et al. Insurance coverage and treatment use under the Affordable Care Act among adults with mental and substance use disorders. Psychiatric services. 2017; 68 :542–548. [PubMed] [Google Scholar]
4. McGuire TG, Newhouse JP, Normand S-L, et al. Assessing incentives for service-level selection in private health insurance exchanges. Journal of Health Economics. 2014; 35 :47–63. [PMC free article] [PubMed] [Google Scholar]
5. Cutler DM, Zeckhauser RJ. Adverse Selection in Health Insurance. In: Garber AM, editor. Frontiers in Health Policy Research. Vol. 1. MIT; 1998. [Google Scholar]
6. Pear R. New York Times. New York, New York: Most Health Insurance Co-ops Are Losing Money, Federal Audit Finds; p. 2015. [Google Scholar]
7. Ettner SL, Frank RG, McGuire TG, et al. Risk adjustment of mental health and substance abuse payments. Inquiry. 1998:223–239. [PubMed] [Google Scholar]
8. McGuire TG, Sinaiko AD. Regulating a Health Insurance Exchange: Implications for Individuals With Mental Illness. Psychiatric Services. 2010; 61 :1074–1080. [PubMed] [Google Scholar]
9. Montz E, Layton T, Busch AB, et al. Risk-Adjustment Simulation: Plans May Have Incentives To Distort Mental Health And Substance Use Coverage. Health Affairs. 2016; 35 :1022–1028. [PMC free article] [PubMed] [Google Scholar]
10. Barry CL, Goldman HH, Huskamp HA. Federal parity in the evolving mental health and addiction care landscape. Health Affairs. 2016; 35 :1009–1016. [PubMed] [Google Scholar]
11. Berry KN, Huskamp HA, Goldman HH, et al. A tale of two states: do consumers see mental health insurance parity when shopping on state exchanges? Psychiatric services (Washington, DC) 2015; 66 :565–567. [PubMed] [Google Scholar]
12. Giovannelli J, Lucia K. Amid Market Uncertainty, Trump Administration Retreats from Health Plan Oversight. To the Point: The Commonwealth Fund. 2017 [Google Scholar]
13. –removed for blind review14. Kemper P, Blumenthal D, Corrigan JM, et al. The design of the community tracking study: a longitudinal study of health system change and its effects on people. Inquiry. 1996:195–206. [PubMed] [Google Scholar]
15. Kaiser Family Foundation. State health facts: Marketplace Enrollment by Metal Level. 2016 [Google Scholar]
16. Olfson M. The Rise of Primary Care Physicians in Provision of US Mental Health Care. Journal of Health Politics, Policy and Law. 2016 [PubMed] [Google Scholar]
17. Olfson M, Blanco C, Wang S, et al. National trends in the mental health care of children, adolescents, and adults by office-based physicians. JAMA psychiatry. 2014; 71 :81–90. [PubMed] [Google Scholar]
18. Gabel JR, Lore R, McDevitt RD, et al. More than half of individual health plans offer coverage that falls short of what can be sold through exchanges as of 2014. Health Affairs. 2012; 31 :1339–1348. [PubMed] [Google Scholar]
19. Horgan CM, Stewart MT, Reif S, et al. Behavioral health services in the changing landscape of private health plans. Psychiatric Services. 2016; 67 :622–629. [PMC free article] [PubMed] [Google Scholar]
20. McGuire TG. Achieving Mental Health Care Parity Might Require Changes In Payments And Competition. Health Affairs. 2016; 35 :1029–1035. [PMC free article] [PubMed] [Google Scholar]
21. Cama S, Malowney M, Smith AJB, et al. Availability of Outpatient Mental Health Care by Pediatricians and Child Psychiatrists in Five U.S. Cities. International Journal of Health Services. 2017 [PubMed] [Google Scholar]
22. Bauman N, Bello J, Coe E, et al. McKinsey Center for US Health System Reform. McKinsey & Compan; 2015. Hospital networks: Evolution of the configurations on the 2015 exchanges. [Google Scholar]
23. Polsky D, Zhang Y, Yasaitis L, et al. Trends in Physician Networks in the Marketplace in 2016. Philadelphia, PA: 2016. [Google Scholar]
24. Polsky D, Cidav Z, Swanson A. Marketplace Plans With Narrow Physician Networks Feature Lower Monthly Premiums Than Plans With Larger Networks. Health Affairs. 2016; 35 :1842–1848. [PubMed] [Google Scholar]
25. Morrisey MA, Rivlin AM, Nathan RP, et al. Five-state Study of ACA Marketplace Competition. 2017 [Google Scholar]
26. Aaron HJ, Fiedler M, Ginsburg PB, et al. Turmoil in the Individual Insurance Market — Where It Came From and How to Fix It. New England Journal of Medicine. 2017; 377 :314–315. [PubMed] [Google Scholar]
27. Johnson CY. Major Obamacare insurer pulls out of Ohio, leaving big gaps in coverage. Washington Post. 2017 [Google Scholar]
28. Kaiser Health News. Some States To Be Left With Few Or No ACA Options After Aetna’s Pullback. 2016 [Google Scholar]